The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

The recent pandemic caused by the SARS-CoV-2 virus continues to be an enormous global
challenge faced by the healthcare sector. Availability of new vaccines and drugs targeting …

SARS-CoV-2 is a respiratory virus that causes significant threats to human health. Mucosal
immunity provides a first-line defense to prevent the infection of SARS-CoV-2 in the …

Background Acute necrotizing encephalopathy (ANE) is a devastating neurologic condition
that can arise following a variety of systemic infections, including influenza and SARS-Cov …

Gut microbiota (GM) modulation can be investigated as possible solution to enhance
recovery after COVID-19. An open-label, single-center, single-arm, pilot, interventional study …

Long COVID-19 syndrome is present in 5–10% of patients infected with SARS-CoV-2, and
there is still little information on the predisposing factors that lead to its development. The …

Introduction: COVID-19 has been a major focus of scientific research since early 2020. Due
to its societal, economic, and clinical impact worldwide, research efforts aimed, among other …

Millions of publications and thousands of clinical trials have not led to the discovery of an
effective treatment for COVID-19. We believe that the reason for this is the inaccurate …

Introduction In coronavirus disease (COVID-19), inflammation takes center stage, with a
cascade of cytokines released, contributing to both inflammation and lung damage. The …

This study attempted to explore pro-inflammatory and anti-inflammatory responses in
patients with mild/moderate coronavirus disease 19 (COVID-19). Eight pro-inflammatory (IL …